
Opinion|Videos|April 8, 2024
Acknowledging Opportunities for Further Research in AD Management
Author(s)David Rosmarin, MD
David Rosmarin, MD, acknowledges opportunities for further research in diverse populations to continue updating AD treatment guidelines.
Advertisement
Episodes in this series

In the Dermatology Times Expert Perspectives series "Advancements in Atopic Dermatitis: Insights from the 2024 Masterclasses in Dermatology Conference," leading dermatologists discuss the advancements in treatments and data for atopic dermatitis (AD) with hand-foot involvement, diversity in clinical trials, and pearls from the American Academy of Dermatology's (AAD) AD treatment guidelines.
In this episode, David Rosmarin, MD, of Indiana University in Indianapolis, acknowledges opportunities for further research in diverse populations to continue updating AD treatment guidelines.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Social Media Mythbusters: The Summer Skin Care "Shutdown"
2
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
3
ED Treatment Gaps Persist for Pediatric Atopic Dermatitis
4
Breakout Bulletin: July 13-July 17
5
















